| Basics |
LivaNova PLC Ordinary Shares
LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
|
| IPO Date: |
October 19, 2015 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$3.46B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.93 | 1.47%
|
| Avg Daily Range (30 D): |
$0.83 | 1.50%
|
| Avg Daily Range (90 D): |
$0.79 | 1.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.4M |
| Avg Daily Volume (30 D): |
.5M |
| Avg Daily Volume (90 D): |
.48M |
| Trade Size |
| Avg Trade Size (Sh.): |
66 |
| Avg Trade Size (Sh.) (30 D): |
46 |
| Avg Trade Size (Sh.) (90 D): |
44 |
| Institutional Trades |
| Total Inst.Trades: |
6,461 |
| Avg Inst. Trade: |
$2.48M |
| Avg Inst. Trade (30 D): |
$2.95M |
| Avg Inst. Trade (90 D): |
$3.2M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.32M |
| Avg Closing Trade (30 D): |
$5.19M |
| Avg Closing Trade (90 D): |
$5.21M |
| Avg Closing Volume: |
54.43K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$.49
|
$.5
|
$-6.01
|
|
Diluted EPS
|
$.49
|
$.5
|
$-6.01
|
|
Revenue
|
$ 357.75M
|
$ 352.52M
|
$ 316.86M
|
|
Gross Profit
|
$ 244.86M
|
$ 238.99M
|
$ 216.25M
|
|
Net Income / Loss
|
$ 26.78M
|
$ 27.16M
|
$ -327.32M
|
|
Operating Income / Loss
|
$ 54.01M
|
$ 54.18M
|
$ 48.62M
|
|
Cost of Revenue
|
$ 112.9M
|
$ 113.54M
|
$ 100.6M
|
|
Net Cash Flow
|
$ 52.44M
|
$ -144.8M
|
$ 14.88M
|
|
PE Ratio
|
129.63
|
|
|
|
|
|
